Roivant Sciences Ltd. (ROIV) Balance Sheet
ROIV balance sheet, FY2026
March 31, 2026 · U.S. dollars$5.73B assets = $435.6M liabilities + $5.29B equity
Both columns are drawn to the same scale: what ROIV owns equals what it owes plus shareholders’ equity. Hover a block for its value.
ROIV financial health
Descriptive bands, not a rating. Fiscal FY2026.
ROIV balance sheet trends, FY2019–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $1.39BFY2019 | $5.73BFY2026 | +22.4%/yr | |
| Total liabilities | $450.5MFY2019 | $435.6MFY2026 | −0.5%/yr | |
| Shareholders’ equity | $937.3MFY2019 | $4.53BFY2026 | +25.2%/yr | |
| Cash & short-term investments | $849.6MFY2019 | $4.30BFY2026 | +26.1%/yr | |
| Total debt | $143.2MFY2019 | $107.4MFY2026 | −4.0%/yr | |
| Net cash (debt) | $706.4MFY2019 | $4.19BFY2026 | +$3.5B | |
| Working capital | $974.2MFY2019 | $4.89BFY2026 | +$3.9B | |
| Book value per share | $4.35FY2019 | $6.52FY2026 | +6.0%/yr | |
| Debt / equity | 0.15FY2019 | 0.02FY2026 | −0.13 | |
| Shares outstanding | 215.4MFY2019 | 693.9MFY2026 | +18.2%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
ROIV assets
ROIV liabilities and equity
ROIV debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
ROIV balance sheet
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & short-term investments | $4.30B | $4.89B | $6.54B | $1.68B | $2.06B | $2.13B | $2.19B | $849.6M |
| Cash & equivalents | $1.42B | $2.72B | $6.54B | $1.68B | $2.06B | $2.13B | $2.19B | $849.6M |
| Short-term investments | $2.87B | $2.17B | $5.4M | $5.0M | $13.6M | $77.7M | — | — |
| Receivables | $789.8M | $0 | $82.8M | $37.6M | $6.7M | $13.8M | $15.3M | $11.0M |
| Inventory | $0 | $0 | $35.3M | $2.8M | −$16.5M | $63.9M | $1 | $0 |
| Other current assets | $81.9M | $113.2M | $72.7M | $76.4M | $95.9M | $0 | $18.5M | $325.0M |
| Total current assets | $5.17B | $5.00B | $6.73B | $1.80B | $2.15B | $2.19B | $2.22B | $1.19B |
| Property, plant & equipment (net) | $92.4M | $101.1M | $66.0M | $92.3M | $86.9M | $77.0M | $73.9M | $11.1M |
| Goodwill & intangible assets | $0 | $0 | $137.8M | $144.9M | $0 | $0 | $0 | $0 |
| Long-term investments | $408.0M | $302.9M | $247.8M | $304.3M | $325.8M | $289.5M | $0 | $0 |
| Other non-current assets | $60.3M | $32.9M | $39.1M | $49.5M | $25.8M | $136.1M | $183.9M | $191.2M |
| Total assets | $5.73B | $5.44B | $7.22B | $2.39B | $2.59B | $2.69B | $2.48B | $1.39B |
| Liabilities | ||||||||
| Accounts payable | $18.0M | $23.7M | $53.2M | $37.8M | $34.6M | $20.6M | $10.3M | $6.2M |
| Short-term debt | $11.1M | $9.8M | $21.9M | $52.4M | $11.4M | $12.3M | $7.8M | $21.2M |
| Deferred revenue | — | $1.2M | $4.2M | $12.4M | $10.1M | $5.9M | $3.6M | $1.4M |
| Total current liabilities | $281.2M | $149.4M | $266.8M | $272.4M | $184.4M | $219.0M | $92.1M | $211.3M |
| Long-term debt | $0 | $0 | $430.6M | $375.5M | $210.0M | $170.3M | $0 | $0 |
| Lease obligations | $107.4M | $100.2M | $57.2M | $65.2M | $73.9M | $74.7M | — | — |
| Other long-term liabilities | $154.4M | $100.3M | $76.6M | $134.1M | $129.3M | $138.4M | $276.2M | $239.2M |
| Total liabilities | $435.6M | $249.7M | $774.0M | $782.0M | $523.7M | $527.7M | $368.4M | $450.5M |
| Shareholders' equity | ||||||||
| Retained earnings (deficit) | −$501.8M | $116.1M | $576.2M | −$3.77B | −$2.76B | −$1.92B | −$1.11B | −$2.31B |
| Accumulated other comprehensive income | $4.4M | $9.4M | −$4.1M | −$2.6M | −$946,000 | $1.4M | −$2.3M | $2.5M |
| Minority interest | $765.0M | $499.6M | $479.9M | $449.8M | $382.0M | — | — | — |
| Total shareholders' equity | $4.53B | $4.69B | $5.97B | $1.16B | $1.66B | $1.90B | $2.03B | $937.3M |
| Key figures | ||||||||
| Total debt | $107.4M | $100.2M | $499.7M | $481.4M | $283.9M | $245.0M | $180.9M | $143.2M |
| Net cash (debt) | $4.19B | $4.79B | $6.04B | $1.20B | $1.78B | $1.89B | $2.00B | $706.4M |
| Working capital | $4.89B | $4.85B | $6.47B | $1.53B | $1.96B | $1.97B | $2.13B | $974.2M |
| Tangible book value | $4.53B | $4.69B | $5.83B | $1.01B | $1.66B | $1.90B | $2.03B | $937.3M |
| Book value per share | $6.52 | $6.46 | $7.18 | $1.62 | $2.47 | $2.77 | $2.97 | $4.35 |
| Shares outstanding | 693.9M | 725.4M | 831.0M | 712.8M | 669.8M | 684.8M | 684.8M | 215.4M |
| Current ratio | 18.37 | 33.47 | 25.24 | 6.60 | 11.64 | 9.99 | 24.09 | 5.61 |
| Quick ratio | 18.08 | 32.71 | 24.83 | 6.31 | 11.21 | 9.80 | 23.89 | 4.07 |
| Debt / equity | 0.02 | 0.02 | 0.08 | 0.42 | 0.17 | 0.13 | 0.09 | 0.15 |
| Equity / assets | 79.0% | 86.2% | 82.6% | 48.5% | 64.1% | 70.6% | 82.0% | 67.5% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $3.84B | $4.30B | $4.53B | $4.39B | $4.50B | $4.89B | $5.15B | $5.39B | $5.39B | $6.54B | $6.67B | $1.41B |
| Cash & equivalents | $1.25B | $1.42B | $1.48B | $1.24B | $1.24B | $2.72B | $1.99B | $1.96B | $1.96B | $6.54B | $6.67B | $1.41B |
| Short-term investments | $2.59B | $2.87B | $3.05B | $3.15B | $3.26B | $2.17B | $3.16B | $3.43B | $3.43B | $5.4M | $5.2M | $5.5M |
| Receivables | $793.2M | $789.8M | $0 | $0 | $0 | $0 | $143.8M | $22.7M | $22.7M | $82.8M | $63.2M | $54.6M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | −$192.5M | $34.0M | $35.3M | $5.2M | $4.9M |
| Other current assets | $106.8M | $81.9M | $129.9M | $125.8M | $112.6M | $113.2M | $73.7M | $584.3M | $357.8M | $72.7M | $67.5M | $78.4M |
| Total current assets | $4.74B | $5.17B | $4.66B | $4.51B | $4.62B | $5.00B | $5.36B | $5.80B | $5.80B | $6.73B | $6.81B | $1.55B |
| Property, plant & equipment (net) | $90.2M | $92.4M | $97.0M | $110.8M | $101.9M | $101.1M | $104.5M | $56.7M | $56.7M | $66.0M | $68.8M | $73.1M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $136.0M | $137.8M | $150.4M | $140.6M |
| Long-term investments | $444.6M | $408.0M | $433.9M | $412.3M | $283.8M | $302.9M | $290.0M | $311.4M | $263.0M | $247.8M | $239.9M | $250.4M |
| Other non-current assets | $29.6M | $60.3M | $34.6M | $27.8M | $31.1M | $32.9M | $33.9M | $36.9M | $0 | $39.1M | $46.8M | $49.8M |
| Total assets | $5.31B | $5.73B | $5.23B | $5.06B | $5.03B | $5.44B | $5.79B | $6.21B | $6.21B | $7.22B | $7.31B | $2.07B |
| Liabilities | ||||||||||||
| Accounts payable | $25.1M | $18.0M | $13.3M | $15.1M | $11.6M | $23.7M | $23.7M | $25.1M | $25.1M | $53.2M | $35.2M | $44.1M |
| Short-term debt | $12.4M | $11.1M | $10.4M | $9.0M | $9.4M | $9.8M | $9.8M | $9.5M | $9.5M | $21.9M | $56.2M | $59.9M |
| Deferred revenue | — | — | — | — | — | $1.2M | $3.0M | $3.4M | $3.4M | $4.2M | $4.7M | $5.8M |
| Total current liabilities | $283.6M | $281.2M | $152.0M | $133.9M | $113.9M | $149.4M | $141.5M | $556.2M | $556.2M | $266.8M | $244.9M | $265.5M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $311.7M | $430.6M | $403.3M | $389.4M |
| Lease obligations | $107.2M | $107.4M | $108.9M | $98.8M | $99.7M | $100.2M | $100.3M | $52.7M | $55.3M | $57.2M | $57.5M | $59.5M |
| Other long-term liabilities | $101.0M | $154.4M | $99.2M | $123.3M | $102.8M | $100.3M | $114.9M | $69.7M | $0 | $76.6M | $79.9M | $84.9M |
| Total liabilities | $384.6M | $435.6M | $251.1M | $257.1M | $216.7M | $249.7M | $256.4M | $626.0M | $626.0M | $774.0M | $728.1M | $739.9M |
| Shareholders' equity | ||||||||||||
| Retained earnings (deficit) | −$900.4M | −$501.8M | −$695.0M | −$429.1M | −$315.6M | $116.1M | $460.4M | $395.6M | $395.6M | $576.2M | $727.3M | −$4.37B |
| Accumulated other comprehensive income | $701,000 | $4.4M | $20.6M | $19.6M | $17.1M | $9.4M | $8.1M | −$18.0M | −$18.0M | −$4.1M | −$27.8M | −$3.1M |
| Minority interest | $690.6M | $765.0M | $705.0M | $443.1M | $470.3M | — | — | — | — | — | — | — |
| Total shareholders' equity | $4.23B | $4.53B | $4.27B | $4.36B | $4.35B | $4.69B | $5.19B | $5.15B | $5.15B | $5.97B | $6.09B | $948.5M |
| Key figures | ||||||||||||
| Total debt | $107.2M | $107.4M | $207.4M | $98.8M | $99.7M | $100.2M | $100.3M | $52.7M | $52.7M | $499.7M | $506.6M | $498.0M |
| Net cash (debt) | $3.73B | $4.19B | $4.32B | $4.29B | $4.40B | $4.79B | $5.05B | $5.33B | $5.33B | $6.04B | $6.16B | $915.7M |
| Working capital | $4.46B | $4.89B | $4.51B | $4.38B | $4.50B | $4.85B | $5.22B | $5.24B | $5.24B | $6.47B | $6.56B | $1.29B |
| Tangible book value | $4.23B | $4.53B | $4.27B | $4.36B | $4.35B | $4.69B | $5.19B | $5.15B | $5.02B | $5.83B | $5.94B | $807.9M |
| Book value per share | $5.87 | $5.57 | $6.13 | $6.41 | $6.39 | $6.63 | $7.18 | $7.01 | $7.01 | $7.43 | $7.21 | $1.23 |
| Shares outstanding | 720.8M | 812.3M | 696.9M | 680.9M | 680.3M | 707.3M | 722.7M | 735.5M | 735.5M | 802.9M | 844.5M | 770.2M |
| Current ratio | 16.72 | 18.37 | 30.66 | 33.70 | 40.54 | 33.47 | 37.91 | 10.43 | 10.43 | 25.24 | 27.79 | 5.84 |
| Quick ratio | 16.34 | 18.08 | 29.81 | 32.77 | 39.55 | 32.71 | 37.39 | 9.72 | 9.72 | 24.83 | 27.50 | 5.53 |
| Debt / equity | 0.03 | 0.02 | 0.05 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.08 | 0.08 | 0.52 |
| Equity / assets | 79.7% | 79.0% | 81.7% | 86.2% | 86.3% | 86.2% | 89.6% | 83.0% | 83.0% | 82.6% | 83.3% | 45.9% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed May 20, 2026); data from EODHD.
ROIV financial position
At the end of fiscal 2026 (March 31, 2026), Roivant Sciences had total assets of $5.7 billion (up 5.4% from a year earlier), total liabilities of $435.6 million and shareholders' equity of $4.5 billion. It held $4.3 billion in cash and short-term investments against $107.4 million of debt, a net cash position of $4.2 billion. Its current ratio was 18.37. In the latest quarter (ended June 30, 2026) total assets were $5.3 billion and equity $4.2 billion.
Related: ROIV income statement, ROIV cash flow statement, ROIV key metrics. See the ROIV stock overview for the latest quote and news.
ROIV balance sheet FAQ
What are Roivant Sciences's total assets?
Roivant Sciences reported total assets of $5.7 billion at the end of fiscal 2026 (March 31, 2026), compared with $5.4 billion a year earlier.
How much debt does Roivant Sciences have?
Roivant Sciences had $107.4 million of total debt at the end of fiscal 2026, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.02.
How much cash does Roivant Sciences have?
Roivant Sciences held $4.3 billion in cash and short-term investments at the end of fiscal 2026; with $107.4 million of debt that is net cash of $4.2 billion.
What is Roivant Sciences's book value?
Roivant Sciences's shareholders' equity (book value) was $4.5 billion at the end of fiscal 2026, or $6.52 per share.
What is Roivant Sciences's current ratio?
Roivant Sciences had current assets of $5.2 billion and current liabilities of $281.2 million, a current ratio of 18.37 (it can cover its short-term obligations).